Corticotroph tumor progression speed after adrenalectomy

in European Journal of Endocrinology
Authors:
Laura BessièneDepartment of Endocrinology, Hôpital Cochin, Reference and Competence Center Rare Adrenal Diseases and for Rare Pituitary Diseases, Assistance Publique–Hôpitaux de Paris, Paris, France

Search for other papers by Laura Bessiène in
Current site
Google Scholar
PubMedClose
https://orcid.org/0000-0002-6524-2428
,
Sandrine MoutelDepartment of Endocrinology, Hôpital Cochin, Reference and Competence Center Rare Adrenal Diseases and for Rare Pituitary Diseases, Assistance Publique–Hôpitaux de Paris, Paris, France

Search for other papers by Sandrine Moutel in
Current site
Google Scholar
PubMedClose
,
Marine LataudDepartment of Radiology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France

Search for other papers by Marine Lataud in
Current site
Google Scholar
PubMedClose
,
Anne JouinotDepartment of Endocrinology, Hôpital Cochin, Reference and Competence Center Rare Adrenal Diseases and for Rare Pituitary Diseases, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Anne Jouinot in
Current site
Google Scholar
PubMedClose
https://orcid.org/0000-0002-7922-2065
,
Fidéline Bonnet-SerranoDepartment of Hormonology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Fidéline Bonnet-Serrano in
Current site
Google Scholar
PubMedClose
,
Jean GuibourdencheDepartment of Hormonology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France

Search for other papers by Jean Guibourdenche in
Current site
Google Scholar
PubMedClose
,
Chiara VillaDepartment of Pathological Cytology and Anatomy, Hôpital Pitié Salpêtrière, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Chiara Villa in
Current site
Google Scholar
PubMedClose
,
Bertrand BaussartDepartment of Neurosurgery, Hôpital Pitié Salpêtrière, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Bertrand Baussart in
Current site
Google Scholar
PubMedClose
https://orcid.org/0000-0003-0735-8278
,
Stephan GaillardDepartment of Neurosurgery, Hôpital Pitié Salpêtrière, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Stephan Gaillard in
Current site
Google Scholar
PubMedClose
https://orcid.org/0000-0001-6555-8919
,
Maxime BaratDepartment of Radiology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Maxime Barat in
Current site
Google Scholar
PubMedClose
,
Anthony DohanDepartment of Radiology, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Anthony Dohan in
Current site
Google Scholar
PubMedClose
,
Xavier BertagnaDepartment of Endocrinology, Hôpital Cochin, Reference and Competence Center Rare Adrenal Diseases and for Rare Pituitary Diseases, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Xavier Bertagna in
Current site
Google Scholar
PubMedClose
,
Bertrand DoussetDepartment of Visceral and Endocrine Surgery, Hôpital Cochin, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Bertrand Dousset in
Current site
Google Scholar
PubMedClose
,
Jérôme BertheratDepartment of Endocrinology, Hôpital Cochin, Reference and Competence Center Rare Adrenal Diseases and for Rare Pituitary Diseases, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Jérôme Bertherat in
Current site
Google Scholar
PubMedClose
https://orcid.org/0000-0003-2551-3008
, and
Guillaume AssiéDepartment of Endocrinology, Hôpital Cochin, Reference and Competence Center Rare Adrenal Diseases and for Rare Pituitary Diseases, Assistance Publique–Hôpitaux de Paris, Paris, France
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, F-75014, Paris, France

Search for other papers by Guillaume Assié in
Current site
Google Scholar
PubMedClose
https://orcid.org/0000-0001-9590-0906
View More View Less

Correspondence should be addressed to G Assié; Email: guillaume.assie@aphp.fr
DOI:
https://doi.org/10.1530/EJE-22-0536
Volume/Issue:
Volume 187: Issue 6
Page Range:
797–807
Article Type:
Research Article
Online Publication Date:
03 Nov 2022
Copyright:
© European Society of Endocrinology 2022
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

Objectives

After bilateral adrenalectomy in Cushing’s disease, corticotroph tumor progression occurs in one-third to half of patients. However, progression speed is variable, ranging from slow to rapid. The aim was to explore corticotroph progression speed, its consequences and its risk factors.

Design

A retrospective single-center observational study.

Methods

In total,103 patients with Cushing’s disease who underwent bilateral adrenalectomy between 1990 and 2020 were included. Clinical, biological, histological and MRI features were collected. Median duration of follow-up after bilateral adrenalectomy was 9.31 years.

Results

In total,44 patients progressed (43%). Corticotroph tumor progression speed ranged from 1 to 40.7 mm per year. Progression speed was not different before and after bilateral adrenalectomy (P  = 0.29). In univariate analyses, predictive factors for rapid corticotroph tumor progression included the severity of Cushing’s disease before adrenalectomy as the cause of adrenalectomy, high ACTH in the year following adrenalectomy and high Ki67 immunopositivity in the tumor. During follow-up, early morning ACTH absolute variation was associated with corticotroph tumor progression speed (P-value = 0.001). ACTH measurement after dynamic testing did not improve this association.

Conclusion

After adrenalectomy, corticotroph progression speed is highly variable and manageable with MRI and ACTH surveillance. Progression speed does not seem related to bilateral adrenalectomy but rather to intrinsic properties of highly proliferative and secreting tumors.

EJE is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 138 138 0
PDF Downloads 181 181 0

 

  • Collapse
  • Expand
Print ISSN:
0804-4643
Online ISSN:
1479-683X

     European Society of Endocrinology

Copyright:
© European Society of Endocrinology 2022
Page(s):
11
Article Type:
Research Article
Received Date:
17 Jun 2022
Accepted Date:
06 Oct 2022
Print Publication Date:
01 Dec 2022
Online Publication Date:
03 Nov 2022
Sept 2018 onwards Past Year Past 30 Days
Abstract Views 4501 4501 358
Full Text Views 138 138 0
PDF Downloads 181 181 0
  • 1

    Dallapiazza RF, Oldfield EH, Jane JA. Surgical management of Cushing’s disease. Pituitary 2015 18 211–216. (https://doi.org/10.1007/s11102-015-0646-5)

  • 2

    Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL, Drake WM & Monson JP et al.Long-term remission and recurrence rates in Cushing’s disease: predictive factors in a single-centre study. European Journal of Endocrinology 2013 168 639–648. (https://doi.org/10.1530/EJE-12-0921)

    • Search Google Scholar
    • Export Citation
  • 3

    Bertagna X, Guignat L. Approach to the Cushing’s disease patient with persistent/recurrent hypercortisolism after pituitary surgery. Journal of Clinical Endocrinology and Metabolism 2013 98 1307–1318. (https://doi.org/10.1210/jc.2012-3200)

    • Search Google Scholar
    • Export Citation
  • 4

    Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B & Regis J et al.Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 2009 94 3400–3407. (https://doi.org/10.1210/jc.2008-2772)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Estrada J, Boronat M, Mielgo M, Magallón R, Millan I, Díez S, Lucas T, Barceló B. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. New England Journal of Medicine 1997 336 172–177. (https://doi.org/10.1056/NEJM199701163360303)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Starke RM, Williams BJ, Vance ML, Sheehan JP. Radiation therapy and stereotactic radiosurgery for the treatment of Cushing’s disease: an evidence-based review. Current Opinion in Endocrinology, Diabetes, and Obesity 2010 17 356–364. (https://doi.org/10.1097/MED.0b013e32833ab069)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Jornayvaz FR, Assie G, Bienvenu-Perrard M, Coste J, Guignat L, Bertherat J, Silvera S, Bertagna X, Legmann P. Pregnancy does not accelerate corticotroph tumor progression in Nelson’s syndrome. Journal of Clinical Endocrinology and Metabolism 2011 96 E658–E662. (https://doi.org/10.1210/jc.2010-2235)

    • Search Google Scholar
    • Export Citation
  • 8

    Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet 2015 386 913–927. (https://doi.org/10.1016/S0140-6736(1461375-1)

  • 9

    Nieman LK, Biller BMK, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A & Endocrine Society. Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2015 100 2807–2831. (https://doi.org/10.1210/jc.2015-1818)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Fountas A, Lim ES, Drake WM, Powlson AS, Gurnell M, Martin NM, Seejore K, Murray RD, MacFarlane J & Ahluwalia R et al.Outcomes of patients with Nelson’s syndrome after primary treatment: a multicenter study from 13 UK pituitary centers. Journal of Clinical Endocrinology and Metabolism 2020 105 dgz200. (https://doi.org/10.1210/clinem/dgz200)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES. Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death. European Journal of Endocrinology 2009 160 233–237. (https://doi.org/10.1530/EJE-08-0550)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Platt R Two essays on the practice of medicine. Lancet 1947 2 305–307. (https://doi.org/10.1016/s0140-6736(4790291-2)

  • 13

    Nelson DH, Meakin JW, Dealy JB Jr, Matson DD, Emerson Jr K, Thorn GW. ACTH-producing tumor of the pituitary gland. New England Journal of Medicine 1958 259 161–164. (https://doi.org/10.1056/NEJM195807242590403)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Assié G, Bahurel H, Coste J, Silvera S, Kujas M, Dugué MA, Karray F, Dousset B, Bertherat J & Legmann P et al.Corticotroph tumor progression after adrenalectomy in Cushing’s disease: a reappraisal of Nelson’s syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 172–179. (https://doi.org/10.1210/jc.2006-1328)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Reincke M, Albani A, Assie G, Bancos I, Brue T, Buchfelder M, Chabre O, Ceccato F, Daniele A & Detomas M et al.Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations. European Journal of Endocrinology 2021 184 P1–P16. (https://doi.org/10.1530/EJE-20-1088)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Barnett AH, Livesey JH, Friday K, Donald RA, Espiner EA. Comparison of preoperative and postoperative ACTH concentrations after bilateral adrenalectomy in Cushing’s disease. Clinical Endocrinology 1983 18 301–305. (https://doi.org/10.1111/j.1365-2265.1983.tb03215.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    McCance DR, Russell CFJ, Kennedy TL, Hadden DR, Kennedy L, Atkinson AB. Bilateral adrenalectomy: low mortality and morbidity in Cushing’s disease. Clinical Endocrinology 1993 39 315–321. (https://doi.org/10.1111/j.1365-2265.1993.tb02371.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Pereira MAA, Halpern A, Salgado LR, Mendonça BB, Nery M, Liberman B, Streeten DHP, Wajchenberg BL. A study of patients with Nelson’s syndrome. Clinical Endocrinology 1998 49 533–539. (https://doi.org/10.1046/j.1365-2265.1998.00578.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Cohen AC, Goldney DC, Danilowicz K, Manavela M, Rossi MA, Gómez RM, Cross GE, Bruno OD. Long-term outcome after bilateral adrenalectomy in Cushing’s disease with focus on Nelson’s syndrome. Archives of Endocrinology and Metabolism 2019 63 470–477. (https://doi.org/10.20945/2359-3997000000144)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. Journal of Clinical Endocrinology and Metabolism 1996 81 2647–2652. (https://doi.org/10.1210/jcem.81.7.8675592)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Graffeo CS, Perry A, Carlstrom LP, Meyer FB, Atkinson JLD, Erickson D, Nippoldt TB, Young WF, Pollock BE, Gompel JJV. Characterizing and predicting the Nelson-Salassa syndrome. Journal of Neurosurgery 2017 127 1277–1287. (https://doi.org/10.3171/2016.9.JNS161163)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Kasperlik-Załuska AA, Bonicki W, Jeske W, Janik J, Zgliczyński W, Czernicki Z. Nelson’s syndrome – 46 years later: clinical experience with 37 patients. Zentralblatt für Neurochirurgie 2006 67 14–20. (https://doi.org/10.1055/s-2006-921430)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Kemink L, Pieters G, Hermus A, Smals A, Kloppenborg P. Patient’s age is a simple predictive factor for the development of Nelson’s syndrome after total adrenalectomy for Cushing’s disease. Journal of Clinical Endocrinology and Metabolism 1994 79 887–889. (https://doi.org/10.1210/jcem.79.3.8077377)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Mehta GU, Sheehan JP, Vance ML. Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing’s disease on the incidence of Nelson’s syndrome. Journal of Neurosurgery 2013 119 1493–1497. (https://doi.org/10.3171/2013.7.JNS13389)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Jenkins PJ, Trainer PJ, Plowman PN, Shand WS, Grossman AB, Wass JA, Besser GM. The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing’s syndrome. Journal of Clinical Endocrinology and Metabolism 1995 80 165–171. (https://doi.org/10.1210/jcem.80.1.7829606)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Gil-Cárdenas A, Herrera MF, Díaz-Polanco A, Rios JM, Pantoja JP. Nelson’s syndrome after bilateral adrenalectomy for Cushing’s disease. Surgery 2007 141 147–15 1; discussion 151. (https://doi.org/10.1016/j.surg.2006.12.003)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Losa M, Bianchi R, Barzaghi R, Giovanelli M, Mortini P. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing’s disease. Journal of Clinical Endocrinology and Metabolism 2009 94 3322–3328. (https://doi.org/10.1210/jc.2009-0844)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Bahurel-Barrera H, Assie G, Silvera S, Bertagna X, Coste J, Legmann P. Inter- and intra-observer variability in detection and progression assessment with MRI of microadenoma in Cushing’s disease patients followed up after bilateral adrenalectomy. Pituitary 2008 11 263–269. (https://doi.org/10.1007/s11102-008-0123-5)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ. Long-term results of total adrenalectomy for Cushing’s disease. World Journal of Surgery 2000 24 108–113. (https://doi.org/10.1007/s002689910020)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Kasperlik-Załuska AA, Nielubowicz J, Wisławski J, Hartwig W, Załuska J, Jeske W, Migdalska B. Nelson’s syndrome: incidence and prognosis. Clinical Endocrinology 1983 19 693–698. (https://doi.org/10.1111/j.1365-2265.1983.tb00046.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Kelly WF, MacFarlane IA, Longson D, Davies D, Sutcliffe H. Cushing’s disease treated by total adrenalectomy: long-term observations of 43 patients. Quarterly Journal of Medicine 1983 52 224–231.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Moreira AC, Castro M, Machado HR. Longitudinal evaluation of adrenocorticotrophin and beta-lipotrophin plasma levels following bilateral adrenalectomy in patients with Cushing’s disease. Clinical Endocrinology 1993 39 91–96. (https://doi.org/10.1111/j.1365-2265.1993.tb01756.x)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C. How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers 2020 12 E514. (https://doi.org/10.3390/cancers12020514)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K & Saeki Y et al.Mutations in the deubiquitinase gene USP8 cause Cushing’s disease. Nature Genetics 2015 47 31–38. (https://doi.org/10.1038/ng.3166)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Hayashi K, Inoshita N, Kawaguchi K, Ibrahim Ardisasmita A, Suzuki H, Fukuhara N, Okada M, Nishioka H, Takeuchi Y & Komada M et al.The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing’s disease. European Journal of Endocrinology 2016 174 213–226. (https://doi.org/10.1530/EJE-15-0689)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Pérez-Rivas LG, Theodoropoulou M, Puar TH, Fazel J, Stieg MR, Ferraù F, Assié G, Gadelha MR, Deutschbein T & Fragoso MC et al.Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson’s tumor. European Journal of Endocrinology 2018 178 57–63. (https://doi.org/10.1530/EJE-17-0634)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A, Letourneur F, Diry S, Diedisheim M & Izac B et al.Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 2020 37 123 .e5–134.e5. (https://doi.org/10.1016/j.ccell.2019.11.002)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Lindberg K, Kouti A, Ziegelitz D, Hallén T, Skoglund T, Farahmand D. Three-dimensional volumetric segmentation of pituitary tumors: assessment of inter-rater agreement and comparison with conventional geometric equations. Journal of Neurological Surgery: Part B, Skull Base 2018 79 475–481. (https://doi.org/10.1055/s-0037-1618577)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Pivonello R, De Martino MC, Cappabianca P, De Leo M, Faggiano A, Lombardi G, Hofland LJ, Lamberts SWJ, Colao A. The medical treatment of Cushing’s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. Journal of Clinical Endocrinology and Metabolism 2009 94 223–230. (https://doi.org/10.1210/jc.2008-1533)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Ferriere A, Cortet C, Chanson P, Delemer B, Caron P, Chabre O, Reznik Y, Bertherat J, Rohmer V & Briet C et al.Cabergoline for Cushing’s disease: a large retrospective multicenter study. European Journal of Endocrinology 2017 176 305–314. (https://doi.org/10.1530/EJE-16-0662)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Libé R, Groussin L, Bertherat J. Pasireotide in Cushing’s disease. New England Journal of Medicine 2012 366 2134; author reply 2134–213 5. (https://doi.org/10.1056/NEJMc1204078)

    • Search Google Scholar
    • Export Citation
  • 42

    Perez-Rivas LG, Simon J, Albani A, Tang S, Roeber S, Assié G, Deutschbein T, Fassnacht M, Gadelha MR & Hermus AR et al.TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome. Acta Neuropathologica Communications 2022 10 139. (https://doi.org/10.1186/s40478-022-01437-1)

    • PubMed
    • Search Google Scholar
    • Export Citation